Aarkstore - Fatigue-Pipeline Insights, 2014

1
Fatigue-Pipeline Insights, 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/77057/-fatigue
  -pipeline-insights-2014

2
Summary

• DelveInsights, Fatigue-Pipeline Insights, 2014,
  report provides comprehensive insights about
  pipeline drugs across this indication. A key
  objective of the report is to establish the
  understanding for all the pipeline drugs that
  fall under Fatigue. This report provides
  information on the therapeutic development based
  on the Fatigue dealing with all the pipeline
  drugs, comparative analysis at various stages
  covering Filed, Phase III, Phase II, Phase I, IND
  filed, Preclinical, Discovery and unknown stages,
  therapeutics assessment by monotherapy and
  combination products and molecule type drug
  information. The report also covers the companies
  information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Note This report requires
  certain updates. We have all the information
  available but require 3 business days to complete
  the process and ensure it is as up-to-date as
  possible. Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated Indication.

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of FatigueThe report
  provides pipeline products under drug profile
  section which includes product description, MOA,
  licensors collaborators, development partner
  and chemical informationCoverage of the Fatigue
  pipeline on the basis of target, MOA, route of
  administration, technology involved and molecule
  typeThe report reviews key players involved in
  the therapeutics development for Fatigue and also
  provide company profilingThe report also gives
  the information of dormant and discontinued
  pipeline projects Pipeline products coverage
  based on various stages of development ranging
  from preregistration till discovery and
  undisclosed stages Provides pipeline assessment
  by monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete Pipeline intelligence
  and complete understanding over therapeutics
  development for FatigueIdentify the relationship
  between the drugs and use it for target finding,
  drug repurposing, and precision medicine.Devise
  corrective measures for pipeline projects by
  understanding Fatigue pipeline depth and focus of
  Indication therapeutics Developing strategic
  initiatives to support your drug development
  activities.Optimize your portfolio and keep you
  in touch with the rapidly changing pharmaceutical
  markets, and make the best decisions for your
  business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and ScopeProvides
  strategically significant competitor information,
  analysis, and insights to formulate effective RD
  development strategies Modify the therapeutic
  portfolio by identifying discontinued projects
  and understanding the factors that drove them
  from pipelineGaining a Full Picture of the
  Competitive Landscape for Evidence based Decisions

7
Table of Content

• Fatigue OverviewFatigue Pipeline
  TherapeuticsFatigue Therapeutics under
  Development by Companies Fatigue Late Stage
  Products (Filed and Phase III)Comparative
  Analysis Fatigue Mid Clinical Stage Products
  (Phase II)Comparative Analysis Fatigue Early
  Clinical Stage Products (Phase I and IND
  Filed)Comparative Analysis Fatigue Discovery
  and Pre-Clinical Stage Products Comparative
  Analysis Drug Candidate ProfilesFatigue
  Therapeutics Assessment Assessment by
  Monotherapy Products 

8
Table of Content

• Assessment by Combination Products Assessment by
  Route of Administration Assessment by Molecule
  Type Fatigue Discontinued Products Fatigue
  Dormant ProductsCompanies Involved in
  Therapeutics Development for Fatigue Appendix Me
  thodology Contact Us Disclaimer

9
List of Tables

• Number of Products under Development for Fatigue,
  2014Number of Products under Development by
  Companies Comparative Analysis by Late Clinical
  Stage Products (Filed and Phase III),
  2014Comparative Analysis Mid Clinical Stage
  Products (Phase II), 2014Comparative Analysis
  Early Clinical Stage Products (Phase I and IND
  Filed), 2014Comparative Analysis Discovery and
  Pre-Clinical Stage Products, 2014Drug Candidates
  ProfilesFatigue Assessment by Monotherapy
  Products Fatigue Assessment by Combination
  Products Fatigue Assessment by Route of
  Administration 

10
List of Tables

• Fatigue Assessment by Stage and Route of
  Administration Fatigue Assessment by Molecule
  Type Fatigue Assessment by Stage and Molecule
  Type Fatigue Therapeutics Discontinued
  Products Fatigue Therapeutics Dormant
  ProductsProducts under Development by Companies,
  2014

11
List of Figures

• Number of Products under Development for Fatigue,
  2014Late Clinical Stage Products (Filed and
  Phase III), 2014Mid Clinical Stage Products
  (Phase II), 2014Early Clinical Stage Products
  (Phase I and IND Filed), 2014Discovery and
  Pre-Clinical Stage Products, 2014Fatigue
  Assessment by Monotherapy Products Fatigue
  Assessment by Combination Products Fatigue
  Assessment by Route of Administration Fatigue
  Assessment by Stage and Route of
  Administration Fatigue Assessment by Molecule
  Type Fatigue Assessment by Stage and Molecule
  Type

12
Related Reports

• The Mobile Healthcare (mHealth) Bible 2014 -
  2020
• Pregnancy Detection Kit Market in the US
  2015-2019
• Global Prenatal and Newborn Genetic Testing
  Market 2015-2019
• Global Knee Implant market 2015-2019
• Global Isosorbide Market 2015-2019
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review
• Jazz Pharmaceuticals plc (JAZZ) - Financial and
  Strategic SWOT Analysis Review
• Pharmstandard (PHST) - Financial and Strategic
  SWOT Analysis Review
• GLG Life Tech Corporation (GLG) - Financial and
  Strategic SWOT Analysis Review

13

• Fatigue-Pipeline Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights, Fatigue-Pipeline Insights, 2014,
  report provides comprehensive insights about
  pipeline drugs across this indication.
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news